Sai Life Sciences IPO Allotment Status

Summary

Sai Life Sciences IPO has closed with a strong response from investors, achieving a notable final subscription of 10.27 times by December 13, 2024 (Day 3). The public issue demonstrated varied investor interest across categories, with the Qualified Institutional Buyers (QIB) segment leading the momentum. The QIB category showed robust enthusiasm with 29.78 times subscription, reflecting strong institutional investor confidence. The Non-Institutional Investors (NII) category achieved 4.99 times subscription, with bNII portion showing stronger interest at 6.10 times compared to sNII at 2.78 times. The Retail category was subscribed 1.39 times. The Anchor Investors portion was fully subscribed. This book built issue has attracted a total of 6,46,482 applications, indicating moderate market interest in the company's pharmaceutical research and development business model.

How to Check Sai Life Sciences IPO Allotment Status:

How to Check Sai Life Sciences IPO Allotment Status on the Registrar's Site?

• Visit the web portal of Kfin Technologies Limited (https://ris.kfintech.com/ipostatus/)
• From the dropdown menu, select Sai Life Sciences IPO
• Choose one of the following modes: PAN ID, Demat Account number, or Application number
• Enter the information relevant to the mode you have chosen
• For security purposes, fill out the captcha accurately
• Click "Submit"

How to Check Sai Life Sciences IPO Allotment Status on BSE/NSE:

• Visit the BSE or NSE website (https://www.bseindia.com/investors/appli_check.aspx)
• Look for the IPO Allotment Status section
• Select "Sai Life Sciences Limited" from the dropdown menu
• Enter your application number and PAN ID
• Click on 'I am not a robot' and then click "Search"

How to Check IPO Allotment Status in a Bank Account:

• Log into your Internet Banking: Go to your bank's website or mobile app and log in.
• Explore IPO Section: Locate the "IPO Services" or "Application Status" sections by going to the IPO Section. You can find this under the investing or services tab.
• Offer Required Information: You might be asked to provide information like your PAN, application number, or other identifiers.
• Verify Allotment Status: Once you submit your information, an IPO allotment status indicating the available allocation shares should appear.
• Verify Status: To ensure accuracy, you can verify the status with the IPO Registrar or use other resources.

How to Check IPO Allotment Status in a Demat Account:

• Open Your Demat Account and Log in: To access your Demat account, use the mobile app or website of your Depository Participant (DP).
• Find IPO Section: Look for the section titled "IPO" or "Portfolio." Search for any services or entries connected to the IPO.
• Verify IPO Allotment Status: Look through the IPO section to see if the shares you were given are visible in your Demat account. This section often displays the status of your IPO application.
• Verify with Registrar: If the IPO shares are inaccessible, visit the Registrar's website and enter your application data to verify allocation.
• Contact DP service if Needed: If there are any discrepancies or problems, contact your DP's customer service.

Sai Life Sciences IPO Timeline:

Sai Life Sciences IPO Subscription Status 

Sai Life Sciences IPO received 10.27 times subscription with 6,46,482 applications. By December 13, 2024 (Day 3), the detailed subscription status revealed a clear pattern of investor interest:

Subscription Day 3 (Final)

• Total Subscription: 10.27 times
• QIB: 29.78 times
• NII: 4.99 times
• Retail investors: 1.39 times 

Subscription Day 2 (December 12, 2024)

• Total Subscription: 1.26 times
• QIB: 3.20 times
• NII: 0.60 times
• Retail investors: 0.43 times

Subscription Day 1 (December 11, 2024)

• Total Subscription: 0.85 times
• QIB: 2.52 times
• NII: 0.16 times
• Retail investors: 0.19 times

Sai Life Sciences IPO Details 

Sai Life Sciences' initial public offering (IPO) is a book built issue of ₹3,042.62 crores. This offering consists of a fresh issue of 1.73 crore shares aggregating to ₹950.00 crores and an offer for sale of 3.81 crore shares aggregating to ₹2,092.62 crores.

The bidding process commenced on December 11, 2024 and concluded on December 13, 2024. The allotment results are anticipated to be finalised on December 16, 2024. Furthermore, the shares of Sai Life Sciences are set to be listed on BSE and NSE, with a provisional listing date scheduled for December 18, 2024.

The price band is set at ₹522-549 per share. Investors must apply for a minimum lot size of 27 shares, which requires a minimum investment of ₹14,823 for retail investors. For small NII (sNII), the minimum investment is 14 lots (378 shares), totalling ₹207,522, while for big NII (bNII), it is 68 lots (1,836 shares), totalling ₹1,007,964.

Kotak Mahindra Capital Company Limited, Jefferies India Private Limited, Morgan Stanley India Company Pvt Ltd and IIFL Securities Ltd serve as the book running lead managers for the IPO, while Kfin Technologies Limited is designated as the registrar for this offering.